The promise of eye tracking has long been tethered to specialized, often expensive hardware. For a clinician assessing a patient's visual field or a developer building a touchless kiosk, that dependency created a barrier to entry, limiting the technology to niche applications. Blink Technologies is betting that the camera already embedded in your laptop or phone is enough. The company's core proposition is a software layer that uses artificial intelligence to estimate gaze and head pose from a standard RGB video feed, a technical feat that, if clinically validated, could democratize a powerful biometric.
Founded in 2018 and operating with dual hubs in San Jose and Haifa, Blink has raised a reported $24 million to date to pursue this vision [IPS News, 2021]. Its most recent disclosed round was a $14 million Series A in late 2021 [SuperAGI]. The capital is earmarked for a broad assault on the market, with the company's materials pointing to applications ranging from optometry and assistive technology to retail analytics and glasses-free 3D displays [Perplexity Sonar Pro Brief]. For Pulse Raman, the most immediate and tangible impact lies in the first category: turning a ubiquitous sensor into a potential tool for patient care.
The software wedge in a hardware world
The eye-tracking market has been dominated by players like Sweden's Tobii, which often rely on infrared sensors and dedicated hardware to achieve high-precision measurements. Blink's differentiation is its insistence on a camera-only, software-defined approach. By developing proprietary AI models that interpret subtle ocular and facial movements from conventional video, the company aims to eliminate the need for any add-on equipment [Perplexity Sonar Pro Brief]. This isn't just a cost-saving measure, it's a distribution strategy. The technology can be integrated via SDKs across Windows, iOS, macOS, Android, and Linux, theoretically allowing any app or device with a front-facing camera to become gaze-aware [Blink Technologies].
For OEMs and platform developers, the appeal is clear. It lowers the bill of materials and design complexity for new devices wanting gaze-enabled features. For Blink, the bet is that this friction reduction will accelerate adoption, allowing its software to become a background utility, much like a face-detection algorithm is today.
A founding team with a track record for exits
The company's ambition is matched by the pedigree of its leadership. Co-founder and CEO Oren Yogev is a two-time Emmy Award winner who previously founded Replay Technologies, a volumetric video company acquired by Intel in 2016 [The Org] [WSJ, 2016]. Following the acquisition, Yogev served as a corporate vice president at Intel, giving him deep experience in bringing complex computer-vision technologies to a global scale. Co-founder and CTO Gilad Drozdov is listed as an inventor on multiple patent applications for the company's core technology, anchoring the technical vision [Justia Patents Search, 2026].
This combination of commercial exit experience and focused technical invention is a significant asset. It suggests a team that understands not only how to build a novel algorithm but also how to navigate the partnerships and integration challenges required to embed it into other companies' products. The team has grown to about 20 employees, with plans to expand US sales and Israeli engineering [LinkedIn] [Cervin Ventures, 2021].
From retail kiosks to clinical tools
Blink's marketed use cases are intentionally wide, reflecting a strategy to find product-market fit across multiple verticals simultaneously. The company's materials describe a technology that is both an interaction engine and a measurement tool.
- Retail and Digital Signage. Enabling touchless control of kiosks, point-of-sale systems, and digital billboards through gaze [Blink Technologies].
- Display Technology. Powering glasses-free 3D experiences by using head-pose tracking to adjust rendered perspectives in real time [Perplexity Sonar Pro Brief].
- Optometry and Eye Health. Using the software to conduct rapid, precise eye tests, addressing manual process challenges in optometry clinics [Healthcare Tech Outlook, 2024].
This last application is where the technology transitions from a novel interface to a potential medical device. The claim that AI can make eye tests "highly precise and extremely fast" is a direct challenge to existing ophthalmic equipment and would require rigorous clinical validation and regulatory clearance, a path the company has not yet detailed publicly.
The calibration challenge
No technical ambition comes without a counterfactual. For Blink, the primary risk is accuracy. Professional-grade, hardware-based eye trackers are the gold standard for a reason: they control their environment with infrared light to capture consistent, high-fidelity data. A software-only system relying on variable ambient lighting, different camera qualities, and unpredictable user distances must overcome significant signal-to-noise hurdles. While the company claims its platform is "lighter, faster, more energy efficient and affordable" than hardware systems, it has not published peer-reviewed data comparing its gaze-estimation error rates against those clinical standards [Blink Technologies].
The competitive landscape also extends beyond Tobii. Major technology companies, including Apple and Google, are investing heavily in advanced camera-based sensing for augmented reality and accessibility features. Blink's answer likely rests on its focus and its cross-platform agnosticism. As a pure-play software vendor, it can serve Android, Windows, and Linux ecosystems without platform allegiance, and its entire business is predicated on solving this single, hard problem.
The next twelve months
For a company that has been relatively quiet in the press since its 2021 Series A, the coming year will be critical for moving from technology demonstration to commercial proof. Key milestones to watch will be the announcement of first major OEM or platform partnerships, any moves toward FDA or other regulatory pathways for its health claims, and the traction of its developer SDK. Another funding round may also be on the horizon to fuel this expansion, especially if early enterprise or clinical pilots gain momentum.
The ultimate test for Blink Technologies will be whether it can translate algorithmic promise into reliable, everyday utility. In the context of assistive technology, where gaze control can restore independence for individuals with motor impairments, the stakes are particularly human. The standard of care today often involves costly, dedicated hardware that can be difficult to set up and calibrate. A system that works reliably on a consumer-grade tablet or laptop could meaningfully expand access. For optometrists, the current workflow involves manual tests and expensive specialized machines. A software tool that integrates into a standard clinic computer could streamline screenings, though it would need to prove it doesn't sacrifice diagnostic integrity for convenience.
Blink's bet is that the camera is already there. The question it must now answer is whether its AI is precise enough to turn that ubiquitous lens into a window on patient health and human intention.
Sources
- [Blink Technologies] Company Website | https://blinkeye.com/
- [SuperAGI] Blink Technologies, Inc. Research | https://sales.superagi.com/company/blink-technologies,-inc.
- [IPS News, 2021] Blink Technologies Profile | https://www.tryfundable.ai/company/blink-technologies-1
- [Perplexity Sonar Pro Brief] Research Brief on Blink Technologies
- [The Org] Oren Yogev Profile | https://theorg.com/org/blink-technologies/org-chart/oren-yogev
- [WSJ, 2016] Intel Acquires Israeli Virtual Reality Startup | https://www.wsj.com/articles/DJFVW00120160309ec39q7jz1
- [Justia Patents Search, 2026] Gilad Drozdov Patents | https://patents.justia.com/inventor/gilad-drozdo
- [LinkedIn] Blink Technologies Company Page | https://www.linkedin.com/company/blinkeyeai
- [Cervin Ventures, 2021] Blink Technologies Raises $14M in Series A Funding | https://www.cervinventures.com/news/blink-technologies-raises-14m-in-series-a-funding?hs_amp=true
- [Healthcare Tech Outlook, 2024] Blink | Top Ophthalmology Solutions Provider 2024 | https://www.healthcaretechoutlook.com/blink